Antiplatelet therapy after percutaneous coronary intervention

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting

Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies

Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow